Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer
Clinical trial NCT03371979 · COMPLETED
Trial details
- NCT number
- NCT03371979
- Sponsor
- Aeglea Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2021-01-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.